Type 2 Diabetes Treatment Will Soon Be Unavailable

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

On July 26, 2017, GlaxoSmithKline (GSK) announced that they would be discontinuing the manufacturing and sales of Tanzeum, their once-weekly injection for type 2 diabetes.

A pharmaceutical company can decide to discontinue a medication for many reason reasons. Just like any other business, if a product does not sell as expected, the company can decide to stop making it—and this just what happened with Tanzeum.

What is Tanzeum indicated for?

Tanzeum is used, in combination with a healthy diet and exercise, to improve blood sugar in adults with type 2 diabetes.

Why is Tanzeum being discontinued?

GlaxoSmithKline is discontinuing Tanzeum due to the limited prescribing of the medication. There are no known safety concerns.

Your doctor may switch you to other once-weekly injectables like Trulicity or Bydureon.

When will Tanzeum be off the market?

GlaxoSmithKline is recommending that health care professionals switch their patients to a different treatment option as soon as possible. They are alerting patients by updating their consumer website here. Be sure to speak with your doctor if you are currently taking Tanzeum.

GSK is ensuring that Tanzeum will remain available to existing patients until at least the end of June 2018. This will allow for enough time for patients to identify and initiate a satisfactory treatment alternative.

Check out the website for Tanzeum here, or call the GSK Consumer Response Center at 1-888-825-5249.

Put drug prices & coupons in your pocket!
We'll text you a link to download our free Android or iPhone app
Get GoodRx Mobile App

Drugs featured in this story

Filed under